Biocon Ltd.

₹360.4

Biocon Ltd.

Add Alert
Add Watchlist

₹360.4

₹360.4

-11.95 (-3.21%) - 6 Aug 2025 04:26 PM

About Company

Biocon Limited is engaged in the manufacture of biotechnology products and research services. It is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.

Market Cap. ₹ 48,184 Cr.
52 Week - High/Low ₹ 406/291
P/E Ratio 70.94
P/B Ratio 4.18
Enterprise Value ₹ 50,294 Cr.
ROE % 5.48
RSI Value 36.03
EMA 50 369.6
EMA 200 349.62
Market Cap. ₹ 48,184 Cr.
52 Week - High/Low ₹ 406/291
P/E Ratio 42.70
P/B Ratio 2.23
Enterprise Value ₹ 60,557 Cr.
ROE % 7.03
RSI Value 36.03
EMA 50 369.6
EMA 200 349.62

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.